[HTML][HTML] Energy metabolism in the liver

L Rui - Comprehensive physiology, 2014 - ncbi.nlm.nih.gov
The liver is an essential metabolic organ, and its metabolic activity is tightly controlled by
insulin and other metabolic hormones. Glucose is metabolized into pyruvate through …

The new biology and pharmacology of glucagon

TD Müller, B Finan, C Clemmensen… - Physiological …, 2017 - journals.physiology.org
In the last two decades we have witnessed sizable progress in defining the role of
gastrointestinal signals in the control of glucose and energy homeostasis. Specifically, the …

Fibroblast growth factor 21—metabolic role in mice and men

H Staiger, M Keuper, L Berti… - Endocrine …, 2017 - academic.oup.com
Since its identification in 2000, the interest of scientists in the hepatokine fibroblast growth
factor (FGF) 21 has tremendously grown, and still remains high, due to a wealth of very …

Islet α cells and glucagon—critical regulators of energy homeostasis

JE Campbell, DJ Drucker - Nature reviews endocrinology, 2015 - nature.com
Glucagon is secreted from islet α cells and controls blood levels of glucose in the fasting
state. Impaired glucagon secretion predisposes some patients with type 1 diabetes mellitus …

[HTML][HTML] Brown and beige adipose tissues in health and disease

L Rui - Comprehensive Physiology, 2017 - ncbi.nlm.nih.gov
Brown and beige adipocytes arise from distinct developmental origins. Brown adipose tissue
(BAT) develops embryonically from precursors that also give to skeletal muscle. Beige fat …

[HTML][HTML] Inventing new medicines: the FGF21 story

A Kharitonenkov, AC Adams - Molecular metabolism, 2014 - Elsevier
Since the discovery of insulin in 1921, protein therapeutics have become vital tools in the
treatment of diabetes mellitus. This heritage has been extended with the comparatively …

[HTML][HTML] Action and therapeutic potential of oxyntomodulin

A Pocai - Molecular metabolism, 2014 - Elsevier
Oxyntomodulin (OXM) is a peptide hormone released from the gut in post-prandial state that
activates both the glucagon-like peptide-1 receptor (GLP1R) and the glucagon receptor …

FGF21-based pharmacotherapy–potential utility for metabolic disorders

RE Gimeno, DE Moller - Trends in Endocrinology & Metabolism, 2014 - cell.com
Currently available therapies for diabetes or obesity produce modest efficacy and are
usually used in combination with agents targeting cardiovascular risk factors. Fibroblast …

[HTML][HTML] Long-term ketogenic diet causes glucose intolerance and reduced β-and α-cell mass but no weight loss in mice

JH Ellenbroek, L van Dijck, HA Töns… - American Journal …, 2014 - journals.physiology.org
High-fat, low-carbohydrate ketogenic diets (KD) are used for weight loss and for treatment of
refractory epilepsy. Recently, short-time studies in rodents have shown that, besides their …

Circulating follistatin is liver-derived and regulated by the glucagon-to-insulin ratio

JS Hansen, S Rutti, C Arous… - The Journal of …, 2016 - academic.oup.com
Context: Follistatin is a plasma protein recently reported to increase under conditions with
negative energy balance, such as exercise and fasting in humans. Currently, the perception …